cancer diagnostics

Rhythm Biosciences (ASX:RHY) is a medical diagnostics technology company transforming cancer diagnostics through innovative technologies that predict, detect, characterise, and support early intervention. Its flagship blood-based technology ColoSTAT® is a blood-based test for the detection of colorectal cancer in symptomatic patients, and the geneType™ platform is a personalised predictive test portfolio combining genomic and clinical information to predict risk of chronic disease development.

Read more

blood-based diagnosticsgenomic and clinical risk assessmentimmunoassay